The State of the Problem of Achieving Extremely Low LDL Levels
- 1 October 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 27 (37), 3841-3857
- https://doi.org/10.2174/1381612827999210111182030
Abstract
Patients who have achieved very low low-density lipoprotein cholesterol (LDL-C) levels in clinical trials have the lowest cardio-vascular risk. The current clinical guidelines set such concentration for LDL-C as < 1.4 mmol/L. However, the question of minimum permissible target values of the lipids remains unresolved. A number of experimental and clinical studies showed some unfavorable consequences of low LDL-C levels, at the same time, the modern arsenal of lipid lowering drugs allows reducing LDL-C levels to extremely low values.Keywords
This publication has 160 references indexed in Scilit:
- Side Chain-oxidized Oxysterols Regulate the Brain Renin-Angiotensin System through a Liver X Receptor-dependent MechanismOnline Journal of Public Health Informatics, 2011
- Exome Sequencing,ANGPTL3Mutations, and Familial Combined HypolipidemiaThe New England Journal of Medicine, 2010
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locusNature, 2010
- Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: The Three-City StudyAtherosclerosis, 2010
- Plasma Membrane Cholesterol Content Affects Nitric Oxide Diffusion Dynamics and SignalingOnline Journal of Public Health Informatics, 2008
- Statins and Cancer RiskThe American Journal of Medicine, 2008
- Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normalJournal of the American College of Cardiology, 2004
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004